PMID- 37599328 OWN - NLM STAT- MEDLINE DCOM- 20231005 LR - 20240201 IS - 1559-0100 (Electronic) IS - 1355-008X (Print) IS - 1355-008X (Linking) VI - 82 IP - 2 DP - 2023 Nov TI - Incidence and risk factors of asymptomatic bacteriuria in patients with type 2 diabetes mellitus: a meta-analysis. PG - 263-281 LID - 10.1007/s12020-023-03469-6 [doi] AB - BACKGROUND: The prevalence of type 2 diabetes mellitus (T2DM) is increasing each year and has become one of the most prominent health concerns worldwide. Patients with T2DM are prone to infectious diseases, and urinary tract infections are also widespread. Despite a comprehensive understanding of urinary tract infection (UTI), there is a lack of research regarding primary prevention strategies for asymptomatic bacteriuria (ASB). OBJECTIVE: To clarify the incidence and risk factors of asymptomatic urinary tract infection in patients with T2DM by meta-analysis to provide evidence for preventing UTI. Help patients, their families, and caregivers to identify the risk factors of patients in time and intervene to reduce the incidence of ASB in patients with T2DM. Fill in the gaps in existing research. STUDY DESIGN: Meta-analyses were conducted in line with PRISMA guidelines. METHODS: Eleven databases were systematically searched for articles about ASB in T2DM, and the retrieval time was selected from the establishment of the database to February 5, 2023. Literature screening, quality evaluation, and meta-analysis were independently performed by two researchers according to the inclusion and exclusion criteria, and a meta-analysis was performed using Stata 17.0. RESULTS: Fourteen articles were included, including cohort and case-control studies. A meta-analysis of 4044 patients with T2DM was included. The incidence of ASB in patients with T2DM was 23.7%(95% CI (0.183, 0.291); P < 0.001). After controlling for confounding variables, the following risk factors were associated with ASB in patients with T2DM: age (WMD = 3.18, 95% CI (1.91, 4.45), I(2) = 75.5%, P < 0.001), female sex (OR = 1.07, 95% CI(1.02, 1.12), I(2) = 79.3%, P = 0.002), duration of type 2 diabetes (WMD = 2.54, 95% CI (1.53, 5.43), I(2) = 80.7%, P < 0.001), HbA1c (WMD = 0.63, 95% CI (0.43, 0.84), I(2) = 62.6,%. P < 0.001), hypertension (OR = 1.59, 95% CI (1.24, 2.04), I(2) = 0%, <0.001), hyperlipidemia (OR = 1.66, 95% CI (1.27, 2.18), I(2) = 0%, P < 0.001), Neuropathy (OR = 1.81, 95% CI (1.38, 2.37), I(2) = 0%, P < 0.001), proteinuria (OR = 3.00, 95% CI (1.82, 4.95), I(2) = 62.7%, P < 0.001). CONCLUSION: The overall prevalence of ASB in T2DM is 23.7%. Age, female sex, course of T2DM, HbA1C, hypertension, hyperlipidemia, neuropathy, and proteinuria were identified as related risk factors for ASB in T2DM. These findings can provide a robust theoretical basis for preventing and managing ASB in T2DM. CI - (c) 2023. The Author(s). FAU - Dai, Mengqiao AU - Dai M AD - Shanghai University of Traditional Chinese Medicine, School of Nursing, Shanghai, 201203, China. FAU - Hua, Shan AU - Hua S AD - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Yang, Jiechao AU - Yang J AD - Shanghai University of Traditional Chinese Medicine, School of Nursing, Shanghai, 201203, China. FAU - Geng, Dandan AU - Geng D AD - Shanghai University of Traditional Chinese Medicine, School of Nursing, Shanghai, 201203, China. FAU - Li, Weina AU - Li W AD - Shanghai University of Traditional Chinese Medicine, School of Nursing, Shanghai, 201203, China. FAU - Hu, Shuqin AU - Hu S AD - Shanghai University of Traditional Chinese Medicine, School of Nursing, Shanghai, 201203, China. FAU - Chen, Hu AU - Chen H AD - Shanghai University of Traditional Chinese Medicine, School of Nursing, Shanghai, 201203, China. FAU - Liao, Xiaoqin AU - Liao X AD - Shanghai University of Traditional Chinese Medicine, School of Nursing, Shanghai, 201203, China. pomeliao@aliyun.com. LA - eng PT - Journal Article PT - Meta-Analysis PT - Systematic Review DEP - 20230821 PL - United States TA - Endocrine JT - Endocrine JID - 9434444 RN - 0 (Glycated Hemoglobin) SB - IM MH - Humans MH - Female MH - *Bacteriuria/epidemiology/etiology/diagnosis MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Incidence MH - Glycated Hemoglobin MH - Risk Factors MH - *Urinary Tract Infections/etiology/complications MH - Proteinuria/complications MH - *Hyperlipidemias/complications MH - *Hypertension/complications PMC - PMC10543815 OTO - NOTNLM OT - Asymptomatic bacteriuria OT - Incidence OT - Meta-analysis OT - Risk factor OT - Type 2 diabetes COIS- The authors declare no competing interests. EDAT- 2023/08/21 00:41 MHDA- 2023/10/05 06:43 PMCR- 2023/08/21 CRDT- 2023/08/20 23:07 PHST- 2023/03/25 00:00 [received] PHST- 2023/06/28 00:00 [accepted] PHST- 2023/10/05 06:43 [medline] PHST- 2023/08/21 00:41 [pubmed] PHST- 2023/08/20 23:07 [entrez] PHST- 2023/08/21 00:00 [pmc-release] AID - 10.1007/s12020-023-03469-6 [pii] AID - 3469 [pii] AID - 10.1007/s12020-023-03469-6 [doi] PST - ppublish SO - Endocrine. 2023 Nov;82(2):263-281. doi: 10.1007/s12020-023-03469-6. Epub 2023 Aug 21.